NCT04769726 is a NA clinical trial of almonds in Intervention, sponsored by Diabetes Foundation, India.

Who is sponsoring NCT04769726?

NCT04769726 is sponsored by Diabetes Foundation, India.

What drugs are being tested in NCT04769726?

Interventions in NCT04769726: almonds.

What condition does NCT04769726 study?

NCT04769726 studies Intervention.

Is NCT04769726 still recruiting?

NCT04769726 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT04769726

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pre-meal Load of Raw Almonds and Postprandial Hyperglycemia

Completed NA Last updated 21 February 2023

What this trial tests

NA trial testing almonds in Intervention in 60 participants. Completed in 20 June 2021.

Timeline

16 December 2017

Primary endpoint
20 June 2021

20 June 2021

Quick facts

Lead sponsor	Diabetes Foundation, India
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	16 December 2017
Primary completion	20 June 2021
Estimated completion	20 June 2021
Sites	1 location across India

Drugs / interventions tested

almonds

Conditions studied

Intervention — all drugs for Intervention →

Sponsor

Diabetes Foundation, India

Who can join

Adults 18 to 60, any sex, with Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A few studies show the effect of almonds on postprandial hyperglycemia (PPHG); high blood glucose after meals. In our previous study on intervention with almonds, we observed a significant decrease in HbA1C and a small decrease in fasting blood glucose indicating a possible effect of almonds on PPHG. Studies have shown that a preload of a food article that is high in protein, mono-unsaturated fatty acids, fiber, and low in carbohydrates, such as almonds could be helpful in stimulating insulin secretion and help improve postprandial hyperglycemia. The proposed study shall be undertaken to assess the effect of almond supplementation on postprandial hyperglycemia in Asian Indians with prediabetes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Premeal almond load decreases postprandial glycaemia, adiposity and reversed prediabetes to normoglycemia: A randomized controlled trial.
Gulati S, Misra A, Tiwari R, Sharma M, et al · · 2023 · cited 11× · PMID 36963852 · DOI 10.1016/j.clnesp.2022.12.028
Beneficial effects of premeal almond load on glucose profile on oral glucose tolerance and continuous glucose monitoring: randomized crossover trials in Asian Indians with prediabetes.
Gulati S, Misra A, Tiwari R, Sharma M, et al · · 2023 · cited 10× · PMID 36732571 · DOI 10.1038/s41430-023-01263-1

Verify or expand the search:

Other recruiting trials for Intervention

Currently open trials in the same condition.

NCT06978959 — Family Navigator Plus for Foster Parents · NA · recruiting
NCT07361211 — A Multifaceted Intervention to Reduce Obesity Among Preschool Children: Study Protocol for a Randomized Controlled Trial · NA · active not recruiting
NCT06750107 — Testing the Efficacy of Safe South Africa · Phase 3 · active not recruiting
NCT07113626 — Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam · NA · recruiting
NCT06515574 — Effect of Developmental Care on Very Low Birth Weight Infants · NA · recruiting

Other Diabetes Foundation, India trials

Trials by the same sponsor.

NCT07205705 — Impact of Partially Replacing Wheat With Millets or Bengal Gram Flour in Rotis on Glycemia and Prediabetes Reversal · NA · not yet recruiting
NCT06454773 — To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood · Phase 3 · recruiting
NCT06386939 — Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans v · recruiting
NCT06386952 — To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump · recruiting
NCT05925946 — Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04769726 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diabetes Foundation, India
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04769726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing